• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharmacyclics Inc

+ Add to Watchlist


67.224 EUR 0.439 0.65%

As of 10:34:54 ET on 04/17/2014.

Snapshot for Pharmacyclics Inc (PY2)

Open: 63.810 Day's Range: 63.800 - 67.224 Volume: 53
Previous Close: 67.663 52wk Range: 56.410 - 111.830 1-Yr Rtn: +17.76%

Stock Chart for PY2

No chart data available.
  • PY2:GR 67.224
  • 1D
  • 1M
  • 1Y
Interactive PY2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PY2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.3530
Est. PEG Ratio -
Market Cap (M EUR) 5,043.49
Shares Outstanding (M) 75.03
30 Day Average Volume 148
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PY2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PY2

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.

Robert W Duggan "Bob"Chairman/CEOManmeet SoniChief Financial Officer
Mahkam Zanganeh "Maky"Chief Operating OfficerJesse McGreivyChief Medical Officer
More Company Profile & Key Executives for PY2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil